DNCC to Establish Community Clinics in 54 Wards

Linde Bangladesh Ltd has declared a 4,100% cash dividend, the highest since its Dhaka Stock Exchange (DSE) listing. This follows a dramatic 4,596.5% increase in profit to Tk 631.68 crore as of July 31, 2024, compared to Tk 13.45 crore the previous year. The earnings per share (EPS) soared to Tk 415.08 from Tk 8.84, mainly due to a capital gain from selling shares of its subsidiary, Linde Industries Pvt Ltd. Net operating cash flow per share (NOCFPS) also rose to Tk 13.19 from Tk 8.38. Linde's share price jumped 17.83% to Tk 1,547.30 after the dividend announcement.

With the ousting of the Hasina administration and a newfound sense of freedom, people from various walks of life have taken to the streets, demanding rights they feel have been denied for years. The pharmaceutical industry is no exception. According to the BIPA President, such protests have not been seen in the sector for over 50 years.

Renata PLC, a publicly traded pharmaceutical company, has received European approval to market Cabergoline 0.5 mg tablets for treating hyperprolactinemia and Parkinson's disease. This approval, obtained through the decentralized procedure, grants access to several European markets including Ireland, France, Portugal, Italy, Denmark, Sweden, the Netherlands, Norway, and Spain. The tablets will be manufactured at Renata's UK MHRA-approved facility in Gazipur and distributed across Europe through strategic partnerships.

Incepta Pharmaceuticals Ltd., a leading pharmaceutical company in Bangladesh, has provided essential medicines and financial donations to the Bangladesh Air Force to aid flood-affected communities. This initiative aims to accelerate relief efforts. On 25 August, Hasnin Muktadir, vice chairman of Incepta Pharmaceuticals Ltd., presented the contributions at the company’s head office in Tejgaon, with several general managers and senior officials present.

Beximco Pharma has been actively involved in flood relief efforts in Bangladesh by providing extensive relief goods, medicines, and deploying its medical team to the affected areas. Additionally, the company has donated cash and medical supplies to industry associations and humanitarian organizations. In the wake of the devastating floods impacting over 5 million people across eleven districts, Beximco Pharma has reaffirmed its commitment to social responsibility through its CSR programs, which support healthcare, education, and research.

Bangladesh is grappling with a concerning increase in HIV/AIDS cases. The number of new infections and deaths has reached a record high this year, according to the Directorate General of Health Services (DGHS). The story of Ramiza, a victim of human trafficking and subsequent HIV infection, highlights the vulnerabilities of many affected individuals. Despite government efforts to expand testing and treatment services, the number of HIV patients continues to rise.